On June 9, Shares of YY Inc (NYSE:YY) were the target of some unusual options trading activity on Monday. Traders acquired 6,492 put options on the company, StockRatingsNetwork.com reports. This is an increase of approximately 168% compared to the average volume of 2,426 put options. YY Inc (ADR) (NASDAQ:YY) net profit margin is 3.68% and weekly performance is 3.97%. On last trading day company shares ended up $65.96. Analysts mean target price for the company is $95.21. YY Inc (ADR) (NASDAQ:YY) distance from 50-day simple moving average (SMA50) is 3.68 %.
Trulia Inc (NYSE:TRLA) Director Sami Inkinen sold 7,050 shares of Trulia stock in a transaction dated Monday, June 9th. The stock was sold at an average price of $39.09, for a total value of $275,584.50. Following the completion of the transaction, the director now directly owns 706,352 shares in the company, valued at approximately $27,611,300. Trulia Inc (NYSE:TRLA) shares advanced 3.37% in last trading session and ended the day on $39.93. Gross Margin is 82.80% and its return on assets is -6.60%. Trulia Inc (NYSE:TRLA) quarterly performance is 34.99%.
On June 9, Yandex NV(NASDAQ:YNDX) and Mail.ru Group Ltd. (MAIL) gained amid speculation that President Vladimir Putin will adopt a more conciliatory stance toward regulation of Russia’s biggest online companies at a meeting. Yandex NV (NASDAQ:YNDX) shares moved down -0.15% in last trading session and was closed at $33.95, while trading in range of $33.60 – $34.30. Yandex NV (NASDAQ:YNDX) year to date (YTD) performance is -21.32%.
On June 3, Many investors appear to be quite bearish on VIVUS, Inc. (NASDAQ:VVUS) especially if you look at the percentage of the float that is sold short for this stock. Currently, 35.97% of the float is sold short, suggesting an extreme level of bearishness for VVUS, according to Zack. VIVUS, Inc. (NASDAQ:VVUS) ended the last trading day at $5.21. Company weekly volatility is calculated as 4.53% and price to cash ratio as 1.70. VIVUS, Inc. (NASDAQ:VVUS) showed a positive weekly performance of 7.42%.
ON June 5, Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY)’s Ventana Medical Systems, Inc. has entered into a collaboration agreement with MedImmune, the global biologics research and development arm of AstraZeneca (AZN -Analyst Report). Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) On last trading day company shares ended up $38.07 .
Leave a Reply